FindTrial
Sign In

British stomach cancer group trial IV: A randomised trial of cimetidine treatment in gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN45115288
Enrollment
Unknown
Registered
2001-07-01
Start date
1994-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oesophagus, stomach cancer Cancer Oesophagus, stomach

Interventions

Patients are randomised to one of four treatment arms: 1. Arm A: Cimetidine 400 mg twice daily until death. 2. Arm B: Cimetidine 400 mg once daily until death. 3. Arm C: Placebo tablet twice daily u

Sponsors

Cancer Research UK (CRUK) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Biopsy proven adenocarcinoma of the stomach, any stage of disease, whether removed curatively or palliatively, or unresectable 2. Able to swallow tablets 3. No other concurrent cancer at other primary sites 4. No other serious illness, limiting prognosis severely

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026